110
Participants
Start Date
July 21, 2022
Primary Completion Date
July 14, 2025
Study Completion Date
July 14, 2025
Antibiotic
We aim to examine differences in clinical outcomes and failure rates between standard and alternative treatment strategies such as minocycline (or moxifloxacin, ciprofloxacin, ceftazidime) alone or in combination with TMP-SMX, alternative TMP-SMX dosing regimens, or variations in durations of therapy for the treatment of S. maltophilia infections within Methodist Health System (MHS).
Methodist Dallas Medical Center, Dallas
Methodist Health System
OTHER